|
Market Closed -
Euronext Paris
01:55:00 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.7300 EUR | +3.55% |
|
-0.54% | -52.47% |
| 11/09 | Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 11-SEP-2026. | CI |
| 17/08 | AB Science completes settlement and delivery of its private placement |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.59M | - | - | - | - | |
| 357B | |||||
| 66.56B | |||||
| 12.14B | |||||
| 7.5B | |||||
| 4.85B |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
